Is Wall Street Bullish or Bearish on Abbott Laboratories Stock?

With a market cap of $233.1 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells a wide range of medical products across diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. With a strong presence in emerging markets and a history of strategic acquisitions and divestitures, Abbott focuses on advancing healthcare solutions worldwide.

Shares of the North Chicago, Illinois-based company have outperformed the broader market over the past 52 weeks. ABT has increased 28.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 8.9%. Moreover, ABT stock has risen 18.8% on a YTD basis, compared to SPX's 3.5% decline.